# CRVO (CervoMed Inc.) - SEC EDGAR Financial Statements

> CervoMed Inc. reported $8.7K in revenue and a net loss of $28.52M for the trailing twelve months ended September 30, 2026 (down 100.0% year over year), with a -334924.9% operating margin.

- Canonical: https://convexityos.com/fundamentals/CRVO
- Markdown: https://convexityos.com/fundamentals/CRVO.md
- SEC CIK: 0001053691
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:03 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001053691&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $8.7K | -100.0% YoY |
| Operating Income | TTM | -$29.23M | -334924.9% margin |
| Net Income | TTM | -$28.52M | -326822.5% net margin |
| Diluted EPS | TTM | -- | Split-adjusted |
| Free Cash Flow | TTM | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $19.60M | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $4.01M | $9.74M | $7.14M | $0 | -- | -- | -- | -- | -- | -- |
| Research & Development | $21.82M | $18.80M | $8.44M | $1.34M | $8.50M | $9.43M | $6.62M | $5.75M | $5.09M | $7.25M |
| Total Operating Expenses | $32.30M | $27.97M | $14.96M | $3.48M | -- | -- | -- | -- | -- | -- |
| **Operating Income** | -$28.29M | -$18.23M | -$7.81M | -$3.48M | -$24.68M | -$15.97M | -$11.55M | -$18.96M | -$11.35M | -$18.37M |
| **EBITDA** | -- | -- | -- | -$3.48M | -$24.58M | -$15.87M | -$11.45M | -$18.85M | -$11.28M | -$18.35M |
| Interest Income | $1.34M | $1.94M | $219K | $62K | -- | -- | -- | -- | -- | -- |
| Interest Expense | -- | -- | $0 | $587 | -- | -- | -- | $3.0K | $100K | $37K |
| Income Before Tax | -- | -- | -- | -$15.59M | -$24.54M | -$15.86M | -$11.47M | -$18.81M | -$2.42M | -$18.40M |
| Income Tax Expense | $0 | -- | -- | $0 | -$444K | -$1.68M | $333K | -$437K | -$1.06M | -$365K |
| **Net Income** | -$26.97M | -$16.29M | -$2.17M | -$5.80M | -$24.10M | -$14.19M | -$11.80M | -$18.37M | -$1.36M | -$18.04M |
| Basic EPS | -$2.98 | -$2.02 | -$0.82 | -$11.20 | -$12.38 | -$0.30 | -$1.76 | -$8.21 | -$3.16 | -$26.40 |
| **Diluted EPS** | -- | -- | -- | $2,038,891.00 | $1,946,859.00 | $53,831,973.00 | $6,706,509.00 | $3,242,301.00 | -$29.11 | -$26.40 |
| Basic Shares Outstanding | 9.0M | 8.1M | 2.7M | 518.1K | -- | -- | -- | 3.2M | 827.6K | 682.2K |
| Diluted Shares Outstanding | -- | -- | -- | -- | -- | -- | -- | 3.2M | 848.1K | 682.2K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $0 | $0 | $0 | $8.7K | $323K | $1.76M | $1.92M | $2.16M |
| Research & Development | $3.68M | $4.32M | $5.14M | $5.83M | $6.04M | $5.11M | $4.84M | $7.09M |
| Total Operating Expenses | $6.10M | $6.68M | $8.11M | $8.34M | $8.37M | $8.37M | $7.22M | $9.40M |
| **Operating Income** | -$6.10M | -$6.68M | -$8.11M | -$8.33M | -$8.04M | -$6.62M | -$5.30M | -$7.24M |
| Interest Income | $210K | $105K | $147K | $241K | $319K | $368K | $409K | $532K |
| **Net Income** | -$5.90M | -$6.57M | -$7.96M | -$8.09M | -$7.73M | -$6.26M | -$4.89M | -$6.71M |
| Basic EPS | -$0.39 | -$0.64 | -$0.86 | -- | -$0.84 | -$0.70 | -$0.56 | -- |
| Basic Shares Outstanding | 15.1M | 10.2M | 9.3M | -- | 9.3M | 9.0M | 8.7M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $8.24M | $9.00M | $7.79M | $4.09M | $37.31M | $18.52M | $14.18M | $7.99M | $8.90M | $1.55M |
| Short-Term Investments | $12.63M | $29.92M | $0 | $12.41M | $0 | -- | -- | -- | -- | -- |
| **Cash & Short-Term Investments** | $20.90M | $38.92M | $7.79M | $16.50M | $37.31M | $18.52M | $14.18M | $7.99M | $8.90M | $1.55M |
| Other Current Assets | $20K | $206K | $70K | $52K | -- | -- | -- | -- | -- | -- |
| **Total Current Assets** | $22.88M | $43.08M | $9.96M | $4.16M | $37.82M | $18.78M | $14.65M | $8.91M | $9.67M | $1.60M |
| Property, Plant & Equipment, Net | -- | -- | -- | -- | $0 | $149K | $252K | $350K | $461K | $80K |
| Goodwill | -- | -- | -- | -- | -- | -- | -- | $0 | $6.93M | $6.93M |
| Intangible Assets | -- | -- | -- | -- | -- | -- | -- | -- | -- | $8.64M |
| Long-Term Investments | -- | -- | $0 | -- | -- | -- | -- | -- | -- | -- |
| Other Non-Current Assets | -- | $0 | $7.8K | $0 | $16K | $16K | $322K | $298K | $450K | $233K |
| **Total Non-Current Assets** | $0 | $0 | $7.8K | $0 | $16K | $8.95M | $9.46M | $9.29M | $16.48M | $15.88M |
| **Total Assets** | $22.88M | $43.08M | $9.97M | $4.16M | $37.84M | $27.73M | $24.11M | $18.20M | $26.15M | $17.48M |
| Accounts Payable | $1.45M | $1.51M | $662K | $97K | $947K | $546K | $1.25M | $199K | $512K | $1.68M |
| Deferred Revenue (Current) | -- | -- | $0 | $0 | -- | -- | -- | -- | -- | -- |
| **Total Current Liabilities** | $4.66M | $3.88M | -- | -- | $2.93M | $2.44M | $1.72M | $804K | $2.69M | $4.44M |
| Other Non-Current Liabilities | -- | -- | -- | -- | -- | -- | -- | -- | $1.4K | $32K |
| **Total Non-Current Liabilities** | $0 | $0 | -- | -- | $0 | $480K | $2.25M | $1.79M | $2.23M | $3.86M |
| **Total Liabilities** | $4.66M | $3.88M | $2.60M | $13.16M | $2.93M | $2.92M | $3.98M | $2.59M | $4.92M | $8.30M |
| **Total Debt (incl. Leases)** | -- | -- | -- | -- | -- | $149K | $247K | -- | -- | -- |
| Common Stock | $9.3K | $8.7K | $5.7K | $518 | $2.0K | $64K | $33K | $3.4K | $968 | $10K |
| Retained Earnings | -$97.70M | -$70.73M | -$54.44M | -$52.27M | -$130.0M | -$105.9M | -$91.72M | -$79.92M | -$61.55M | -$60.19M |
| Accumulated Other Comp. Income | $5.8K | $56K | $0 | -$35K | $0 | -- | -- | -- | -- | -- |
| **Total Stockholders' Equity** | $18.22M | $39.20M | $7.38M | -$33.29M | $34.91M | $24.81M | $20.13M | $15.61M | $21.23M | $9.18M |
| Total Equity | $18.22M | $39.20M | $7.38M | -$33.29M | -$27.94M | $24.81M | $20.13M | $15.61M | $21.23M | $9.18M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $6.06M | $22.46M | $7.94M | $8.24M | $9.44M | $8.32M | $10.50M | $9.00M |
| Short-Term Investments | $13.54M | $2.48M | $4.98M | $12.63M | $17.86M | $25.21M | $24.74M | $29.92M |
| **Cash & Short-Term Investments** | $19.60M | $24.90M | $12.90M | $20.90M | $27.30M | $33.50M | $35.24M | $38.92M |
| Other Current Assets | $150K | $103K | $86K | $20K | $50K | $42K | $122K | $206K |
| **Total Current Assets** | $21.33M | $25.99M | $15.11M | $22.88M | $30.61M | $38.08M | $38.58M | $43.08M |
| Other Non-Current Assets | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Total Non-Current Assets** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Total Assets** | $21.33M | $25.99M | $15.11M | $22.88M | $30.61M | $38.08M | $38.58M | $43.08M |
| Accounts Payable | $1.62M | $687K | $2.27M | $1.45M | $1.35M | $1.85M | $1.86M | $1.51M |
| **Total Current Liabilities** | $3.97M | -- | -- | $4.66M | -- | -- | -- | $3.88M |
| **Total Non-Current Liabilities** | $0 | -- | -- | $0 | -- | -- | -- | $0 |
| **Total Liabilities** | $3.97M | $3.03M | $4.50M | $4.66M | $4.60M | $4.64M | $3.94M | $3.88M |
| Common Stock | $15K | $14K | $9.3K | $9.3K | $9.3K | $9.3K | $8.7K | $8.7K |
| Retained Earnings | -$118.1M | -$112.2M | -$105.7M | -$97.70M | -$89.61M | -$81.88M | -$75.63M | -$70.73M |
| Accumulated Other Comp. Income | -$18K | $106 | -$208 | $5.8K | $5.8K | -$783 | $21K | $56K |
| **Total Stockholders' Equity** | $17.36M | $22.96M | $10.62M | $18.22M | $26.01M | $33.44M | $34.63M | $39.20M |
| Total Equity | $17.36M | $22.96M | $10.62M | $18.22M | $26.01M | $33.44M | $34.63M | $39.20M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$26.97M | -$16.29M | -$2.17M | -$5.80M | -$24.10M | -$14.19M | -$11.80M | -$18.37M | -$1.36M | -$18.04M |
| Depreciation & Amortization | -- | -- | -- | $0 | $93K | $103K | $98K | $110K | $68K | $25K |
| Stock-Based Compensation | $1.45M | $1.41M | $408K | $334K | $897K | $736K | $516K | $1.22M | $1.24M | $1.39M |
| Change in Receivables | $1.83M | -$1.34M | -$915K | -- | -- | -- | -- | -- | -- | -- |
| Change in Payables | -$67K | $849K | $565K | $79K | -- | -- | -- | -- | -- | -- |
| **Operating Cash Flow** | -$23.45M | -$16.53M | -$7.45M | -$2.57M | -$14.50M | -$13.55M | -$9.86M | -$10.77M | -$12.33M | -$10.77M |
| Capital Expenditure | -- | -- | -- | -- | -- | -- | -- | -- | -$448K | -$2.3K |
| **Free Cash Flow** | -- | -- | -- | -- | -- | -- | -- | -- | -$12.78M | -$10.77M |
| Purchases of Investments | -$25.40M | -$48.10M | $0 | -$37.99M | $0 | -- | -- | -- | -- | -- |
| **Investing Cash Flow** | $18.10M | -$28.66M | $0 | -$12.24M | $4.0K | $0 | -- | -- | -$448K | $8.50M |
| Common Stock Issued | -- | $46.40M | $810K | $0 | $31.09M | $10.83M | $16.00M | $10.85M | -- | -- |
| **Financing Cash Flow** | $4.59M | $46.40M | $11.15M | $0 | $33.30M | $17.89M | $16.04M | $9.87M | $20.12M | $1.83M |
| **Net Change in Cash** | -$764K | $1.21M | $3.70M | -$2.57M | $18.80M | $4.34M | $6.19M | -$905K | $7.34M | -$444K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$5.90M | -$6.57M | -$7.96M | -$8.09M | -$7.73M | -$6.26M | -$4.89M | -$6.71M |
| Stock-Based Compensation | $307K | $362K | $349K | $299K | $292K | $497K | $361K | $338K |
| Change in Receivables | $0 | $0 | $427K | $934K | $1000K | -$732K | $625K | -$1.99M |
| Change in Payables | $930K | -$1.53M | $765K | $95K | -$435K | -$77K | $349K | $429K |
| **Operating Cash Flow** | -$5.07M | -$6.92M | -$8.02M | -$6.58M | -$6.47M | -$6.51M | -$3.89M | -$8.05M |
| Purchases of Investments | -$12.47M | -$2.47M | -$989K | -$4.63M | -$3.92M | -$9.75M | -$7.10M | -$3.63M |
| **Investing Cash Flow** | -$10.97M | $2.53M | $7.71M | $5.37M | $7.58M | -$255K | $5.40M | $9.31M |
| **Financing Cash Flow** | -$358K | $18.91M | $14K | $0 | $0 | $4.59M | $0 | -- |
| **Net Change in Cash** | -$16.40M | $14.52M | -$294K | -$1.20M | $1.12M | -$2.18M | $1.50M | $1.26M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -706.2% | -187.2% | -109.3% | -- | -- | -- | -- | -- | -- | -- |
| **Net Profit Margin** | -673.1% | -167.3% | -30.4% | -- | -- | -- | -- | -- | -- | -- |
| Return on Equity (ROE) | -148.0% | -41.6% | -29.4% | -- | -69.0% | -57.2% | -58.6% | -117.7% | -6.4% | -196.4% |
| Return on Assets (ROA) | -117.9% | -37.8% | -21.8% | -139.6% | -63.7% | -51.2% | -48.9% | -100.9% | -5.2% | -103.2% |
| Current Ratio | 4.91x | 11.11x | -- | -- | 12.92x | 7.71x | 8.51x | 11.09x | 3.59x | 0.36x |
| Quick Ratio | 4.49x | 10.03x | -- | -- | 12.75x | 7.60x | 8.24x | 9.94x | 3.31x | 0.35x |
| Debt to Equity | -- | -- | -- | -- | -- | 0.01x | 0.01x | -- | -- | -- |
| **Revenue Growth (YoY)** | -58.9% | +36.3% | -- | -- | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -334924.9% | -9407.0% | -1488.9% | -706.2% | -441.6% | -315.8% | -224.9% | -187.2% |
| **Net Profit Margin** | -326822.5% | -9160.9% | -1437.8% | -673.1% | -415.4% | -290.8% | -200.6% | -167.3% |
| Return on Equity (ROE) | -164.3% | -132.2% | -282.9% | -148.0% | -98.4% | -67.6% | -53.9% | -41.6% |
| Return on Assets (ROA) | -133.7% | -116.8% | -198.7% | -117.9% | -83.6% | -59.4% | -48.4% | -37.8% |
| Current Ratio | 5.37x | -- | -- | 4.91x | -- | -- | -- | 11.11x |
| Quick Ratio | 4.93x | -- | -- | 4.49x | -- | -- | -- | 10.03x |
| **Revenue Growth (YoY)** | -100.0% | -100.0% | -100.0% | -99.6% | -83.4% | -46.6% | -18.3% | -13.2% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
